Cargando…

Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies

AIM: To summarize the evidence on diabetes risk scores for Latin American populations. METHODS: A systematic review was conducted (CRD42019122306) looking for diagnostic and prognostic models for type 2 diabetes mellitus among randomly selected adults in Latin America. Five databases (LILACS, Scopus...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrillo‐Larco, R. M., Aparcana‐Granda, D. J., Mejia, J. R., Barengo, N. C., Bernabe‐Ortiz, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900051/
https://www.ncbi.nlm.nih.gov/pubmed/31441090
http://dx.doi.org/10.1111/dme.14114
_version_ 1783477269395668992
author Carrillo‐Larco, R. M.
Aparcana‐Granda, D. J.
Mejia, J. R.
Barengo, N. C.
Bernabe‐Ortiz, A.
author_facet Carrillo‐Larco, R. M.
Aparcana‐Granda, D. J.
Mejia, J. R.
Barengo, N. C.
Bernabe‐Ortiz, A.
author_sort Carrillo‐Larco, R. M.
collection PubMed
description AIM: To summarize the evidence on diabetes risk scores for Latin American populations. METHODS: A systematic review was conducted (CRD42019122306) looking for diagnostic and prognostic models for type 2 diabetes mellitus among randomly selected adults in Latin America. Five databases (LILACS, Scopus, MEDLINE, Embase and Global Health) were searched. type 2 diabetes mellitus was defined using at least one blood biomarker and the reports needed to include information on the development and/or validation of a multivariable regression model. Risk of bias was assessed using the PROBAST guidelines. RESULTS: Of the 1500 reports identified, 11 were studied in detail and five were included in the qualitative analysis. Two reports were from Mexico, two from Peru and one from Brazil. The number of diabetes cases varied from 48 to 207 in the derivations models, and between 29 and 582 in the validation models. The most common predictors were age, waist circumference and family history of diabetes, and only one study used oral glucose tolerance test as the outcome. The discrimination performance across studies was ~ 70% (range: 66–72%) as per the area under the receiving‐operator curve, the highest metric was always the negative predictive value. Sensitivity was always higher than specificity. CONCLUSION: There is no evidence to support the use of one risk score throughout Latin America. The development, validation and implementation of risk scores should be a research and public health priority in Latin America to improve type 2 diabetes mellitus screening and prevention.
format Online
Article
Text
id pubmed-6900051
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69000512019-12-20 Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies Carrillo‐Larco, R. M. Aparcana‐Granda, D. J. Mejia, J. R. Barengo, N. C. Bernabe‐Ortiz, A. Diabet Med Systematic Reviews or Meta‐analyses AIM: To summarize the evidence on diabetes risk scores for Latin American populations. METHODS: A systematic review was conducted (CRD42019122306) looking for diagnostic and prognostic models for type 2 diabetes mellitus among randomly selected adults in Latin America. Five databases (LILACS, Scopus, MEDLINE, Embase and Global Health) were searched. type 2 diabetes mellitus was defined using at least one blood biomarker and the reports needed to include information on the development and/or validation of a multivariable regression model. Risk of bias was assessed using the PROBAST guidelines. RESULTS: Of the 1500 reports identified, 11 were studied in detail and five were included in the qualitative analysis. Two reports were from Mexico, two from Peru and one from Brazil. The number of diabetes cases varied from 48 to 207 in the derivations models, and between 29 and 582 in the validation models. The most common predictors were age, waist circumference and family history of diabetes, and only one study used oral glucose tolerance test as the outcome. The discrimination performance across studies was ~ 70% (range: 66–72%) as per the area under the receiving‐operator curve, the highest metric was always the negative predictive value. Sensitivity was always higher than specificity. CONCLUSION: There is no evidence to support the use of one risk score throughout Latin America. The development, validation and implementation of risk scores should be a research and public health priority in Latin America to improve type 2 diabetes mellitus screening and prevention. John Wiley and Sons Inc. 2019-09-06 2019-12 /pmc/articles/PMC6900051/ /pubmed/31441090 http://dx.doi.org/10.1111/dme.14114 Text en © 2019 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Systematic Reviews or Meta‐analyses
Carrillo‐Larco, R. M.
Aparcana‐Granda, D. J.
Mejia, J. R.
Barengo, N. C.
Bernabe‐Ortiz, A.
Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies
title Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies
title_full Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies
title_fullStr Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies
title_full_unstemmed Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies
title_short Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies
title_sort risk scores for type 2 diabetes mellitus in latin america: a systematic review of population‐based studies
topic Systematic Reviews or Meta‐analyses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900051/
https://www.ncbi.nlm.nih.gov/pubmed/31441090
http://dx.doi.org/10.1111/dme.14114
work_keys_str_mv AT carrillolarcorm riskscoresfortype2diabetesmellitusinlatinamericaasystematicreviewofpopulationbasedstudies
AT aparcanagrandadj riskscoresfortype2diabetesmellitusinlatinamericaasystematicreviewofpopulationbasedstudies
AT mejiajr riskscoresfortype2diabetesmellitusinlatinamericaasystematicreviewofpopulationbasedstudies
AT barengonc riskscoresfortype2diabetesmellitusinlatinamericaasystematicreviewofpopulationbasedstudies
AT bernabeortiza riskscoresfortype2diabetesmellitusinlatinamericaasystematicreviewofpopulationbasedstudies